Chemically and genetically immunocompromised mice are not more susceptible than immunocompetent mice to infection with Cryptosporidium muris

Veterinary Parasitology

Volumn 143, Issue 2, 2007, Pages 99-105

  Miller, Thomas A ^a   Ware, Michael W ^a   Wymer, Larry J ^a   Schaefer III, Frank W ^a  

^a U S ENVIRONMENTAL PROTECTION AGENCY   (United States)

Author keywords

Cryptosporidium muris; ID50; Immunosuppression; Infective dose; Methylprednisolone acetate

Indexed keywords

METHYLPREDNISOLONE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; B LYMPHOCYTE; CRYPTOSPORIDIUM MURIS; DISEASE PREDISPOSITION; FEMALE; IMMUNE DEFICIENCY; IMMUNOCOMPETENCE; MOUSE; NONHUMAN; OOCYST; RISK ASSESSMENT; T LYMPHOCYTE;

ANIMALS; ANIMALS, GENETICALLY MODIFIED; B-LYMPHOCYTES; CRYPTOSPORIDIOSIS; CRYPTOSPORIDIUM; DISEASE SUSCEPTIBILITY; IMMUNOCOMPROMISED HOST; IMMUNOSUPPRESSIVE AGENTS; METHYLPREDNISOLONE; MICE; MICE, INBRED C57BL; MICE, INBRED STRAINS; MICE, NUDE; MICE, SCID; OOCYSTS; PARASITE EGG COUNT; SEVERITY OF ILLNESS INDEX; T-LYMPHOCYTES; WATER;

CRYPTOSPORIDIUM; CRYPTOSPORIDIUM MURIS; MUS MUSCULUS;

EID: 33845693534     PISSN: 03044017     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vetpar.2006.08.012     Document Type: Article

References (30)

1. Abbas A.K., and Lichtman A.H. Cellular and Molecular Immunology (2003), W.B. Saunders Co., Philadelphia pp. 81-103
2. Arrowood M.J., and Donaldson K. Improved purification methods for calf-derived Cryptosporidium parvum oocysts using discontinuous sucrose and cesium chloride gradients. J. Eukaryot. Microbiol. 43 (1996) 89S
3. Ash L.R., and Orihel T.C. Parasites: A Guide to Laboratory Procedures and Identification (1987), American Society of Clinical Pathologists Press, Chicago pp. 33-34
4. Cevallos A.M., Bhat N., Verdon R., Hamer D.H., Stein B., Tzipori S., Pereira M.E., Keusch G.T., and Ward H.D. Mediation of Cryptosporidium parvum infection in vitro by mucin-like glycoproteins defined by a neutralizing monoclonal antibody. Infect. Immun. 68 (2000) 5167-5175
5. Chappell C.L., Okhuysen P.C., Sterling C.R., Wang C., Jakubowski W., and DuPont H.L. Infectivity of Cryptosporidium parvum in healthy adults with pre- existing anti-C. parvum serum immunoglobulin G. Am. J. Trop. Med. Hyg. 60 (1999) 157-164
6. Dillingham R.A., Lima A.A., and Guerrant R.L. Cryptosporidiosis: epidemiology and impact. Microbes Infect. 4 (2002) 1059-1066
7. DuPont H.L., Chappell C.L., Sterling C.R., Okhuysen P.C., Rose J.B., and Jakubowski W. The infectivity of Cryptosporidium parvum in healthy volunteers. N. Engl. J. Med. 332 (1995) 855-859
8. Finch G.R., Daniels C.W., Black E.K., Schaefer III F.W., and Belosevic M. Dose response of Cryptosporidium parvum in outbred neonatal CD-1 mice. Appl. Environ. Microbiol. 59 (1993) 3661-3665
9. Franzen C., and Muller A. Cryptosporidia and microsporidia - waterborne diseases in the immunocompormised host. Diagn. Microbiol. Infect. Dis. 34 (1999) 245-262
10. Gantz T. Defensins and host defense. Science 286 (1999) 420-421
11. Griffiths J.K. Human cryptosporidiosis: epidemiology, transmission, clinical disease, treatment, and diagnosis. In: Tzipori S. (Ed). Advances in Parisitology-Opportunistic Protozoa in Humans 40 (1998), Academic Press, London 37-85
12. Heyworth M.F. Parasitic diseases in immunocompromised hosts. Cryptosporidiosis, isosporiasis, and strongyloidiasis. Gastroenterol. Clin. North Am. 25 (1996) 691-707
13. Hicks S.J., Theodoropoulos G., Carrington S.D., and Corfield A.P. The role of mucins in host-parasite interactions. Part I-protozoan parasites. Parasitol. Today 16 (2000) 476-481
14. Kasper L.H., and Buzoni-Gatel D. Ups and downs of mucosal cellular immunity against protozoan parasites. Infect. Immun. 69 (2001) 1-8
15. Landay A.L., and Muirhead K.A. Procedural guidelines for performing immunophenotyping by flow cytometry. Clin. Immunol. Immunopathol. 52 (1989) 48-60
16. Lean I.S., McDonald S.A., Bajaj-Elliott M., Pollok R.C., Farthing M.J., and McDonald V. Interleukin-4 and transforming growth factor beta have opposing regulatory effects on gamma interferon-mediated inhibition of Cryptosporidium parvum reproduction. Infect. Immun. 71 (2003) 4580-4585
17. Matsui T., Fujino T., Kajima J., and Tsuji M. Infectivity and oocyst excretion patterns of Cryptosporidium muris in slightly infected mice. J. Vet. Med. Sci. 63 (2001) 319-320
18. McDonald, V., Bancroft, G., 1993. Cryptosporidium muris in adult mice: a model for investigation of the immunology of mammalian cryptosporidiosis. In: Barta, J.R., Fernando, M.A. (Eds.), Proceedings of the VIth International Coccidiosis Conference. University of Guelph, Guelph, Canada.
19. McDonald V., Deer R., Uni S., Iseki M., and Bancroft G.J. Immune responses to Cryptosporidium muris and Cryptosporidium parvum in adult immunocompetent or immunocompromised (nude and SCID) mice. Infect. Immun. 60 (1992) 3325-3331
20. McDonald V., Robinson H.A., Kelly J.P., and Bancroft G.J. Cryptosporidium muris in adult mice: adoptive transfer of immunity and protective roles of CD4 versus CD8 cells. Infect. Immun. 62 (1994) 2289-2294
21. McDonald V., Robinson H.A., Kelly J.P., and Bancroft G.J. Immunity to Cryptosporidium muris infection in mice is expressed through gut CD4+ intraepithelial lymphocytes. Infect. Immun. 64 (1996) 2556-2562
22. Mead J.R., Arrowood M.J., Sidwell R.W., and Healey M.C. Chronic Cryptosporidium parvum infections in congenitally immunodeficient SCID and nude mice. J. Infect. Dis. 163 (1991) 1297-1304
23. Moncada D.M., Kammanadiminti S.J., and Chadee K. Mucin and Toll-like receptors in host defense against intestinal parasites. Trends Parasitol. 19 (2003) 305-311
24. Nina J.M., McDonald V., Dyson D.A., Catchpole J., Uni S., Iseki M., Chiodini P.L., and McAdam K.P. Analysis of oocyst wall and sporozoite antigens from three Cryptosporidium species. Infect. Immun. 60 (1992) 1509-1513
25. Okhuysen P.C., Chappell C.L., Crabb J.H., Sterling C.R., and DuPont H.L. Virulence of three distinct Cryptosporidium parvum isolates for healthy adults. J. Infect. Dis. 180 (1999) 1275-1281
26. Roberts-Thomson I.G., Stevens D.P., Mahmoud A.A.F., and Warren K.S. Acquired resistance to infection in an animal model of giardiasis. J. Immunology. 117 (1976) 2036-2037
27. Sauch J.F. Purification of Giardia muris cysts by velocity sedimentation. Appl. Environ. Microbiol. 48 (1984) 454-455
28. Ungar B.L., Burris J.A., Quinn C.A., and Finkelman F.D. New mouse models for chronic Cryptosporidium infection in immunodeficient hosts. Infect. Immun. 58 (1990) 961-969
29. Ware M.W., Wymer L., Lindquist H.D., and Schaefer F.W. Evaluation of an alternative IMS dissociation procedure for use with Method 1622: detection of Cryptosporidium in water. J Microbiol. Methods 55 (2003) 575-583
30. Xiao L., Fayer R., Ryan U., and Upton S.J. Cryptosporidium taxonomy: recent advances and implications for public health. Clin. Microbiol. Rev. 17 (2004) 72-97